1,003
Participants
Start Date
March 31, 2009
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
Dimebon
5 mg orally three times daily
Dimebon
20 mg orally three times daily
Placebo comparator
Placebo orally three times daily
New York
Cedarhurst
Albany
Rochester
Jenkintown
Norristown
Washington D.C.
Eaton
Charlottesville
Durham
Atlanta
Jacksonville
Orlando
Deerfield Beach
Miami
Delray Beach
Lexington
Toledo
Beachwood
Indianapolis
Ann Arbor
Middleton
Houston
San Antonio
Austin
Denver
Boulder
Phoenix
Sun City
Tucson
Las Vegas
Los Angeles
Los Alamitos
Paramount
Pasadena
Encino
Escondido
La Jolla
San Diego
Costa Mesa
Newport
Garden Grove
Fresno
San Francisco
Martinez
Honolulu
Seattle
New Haven
Boston
Mount Arlington
Princeton
Providence
Newcastle
Sydney
Brisbane
Adelaide
Geelong
Melbourne
Perth
Antwerp
Leuven
Sint-Truiden
Kuppio
Oulu
Turku
Bordeaux
Concert
Lille
Montpellier
Nice
Toulouse
Berlin
Bochum
Freiburg im Breisgau
Hattingen
Mannheim
Munich
Brescia
Florence
Genoa
Perugia
Rome
Christchurch
Auckland
Malmo
Norrköping
Stockholm
Brentford
Rushden
Glasgow
Worthington
Bath
Blackpool
Bradford
Greater Manchester
London
Newcastle upon Tyne
Norfolk
Oxford
Southampton
Swindon
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
Medivation, Inc.
INDUSTRY